121 related articles for article (PubMed ID: 27331597)
1. Employing Demand-Based Volumetric Forecasting to Identify Potential for and Roles of Devices in Scale-Up of Medical Male Circumcision in Zambia and Zimbabwe.
Fram F; Church F; Sundaram M; Sgaier SK; Ridzon R; Eletskaya M; Nanga A; Gumede-Moyo S; Tambatamba B; Mugurungi O; Ncube G; Xabayu S; Odawo P; Kretschmer S
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S83-9. PubMed ID: 27331597
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Opportunities for Achieving Cost Efficiencies Through the Introduction of PrePex Device Male Circumcision in Adult VMMC Programs in Zambia and Zimbabwe.
Vandament L; Chintu N; Yano N; Mugurungi O; Tambatamba B; Ncube G; Xaba S; Mpasela F; Muguza E; Mangono T; Madidi N; Samona A; Tagar E; Hatzold K
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S90-5. PubMed ID: 27331598
[TBL] [Abstract][Full Text] [Related]
3. A Phase II Randomized Controlled Trial Comparing Safety, Procedure Time, and Cost of the PrePex™ Device to Forceps Guided Surgical Circumcision in Zimbabwe.
Tshimanga M; Mangwiro T; Mugurungi O; Xaba S; Murwira M; Kasprzyk D; Montaño DE; Nyamukapa D; Tambashe B; Chatikobo P; Gundidza P; Gwinji G
PLoS One; 2016; 11(5):e0156220. PubMed ID: 27227679
[TBL] [Abstract][Full Text] [Related]
4. Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia.
Sokal DC; Li PS; Zulu R; Awori QD; Agot K; Simba RO; Combes S; Lee RK; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Barone MA
J Acquir Immune Defic Syndr; 2014 Dec; 67(4):430-7. PubMed ID: 25162816
[TBL] [Abstract][Full Text] [Related]
5. Is the PrePex device an alternative for surgical male circumcision in adolescents ages 13-17 years? Findings from routine service delivery during active surveillance in Zimbabwe.
Mavhu W; Hatzold K; Madidi N; Maponga B; Dhlamini R; Munjoma M; Xaba S; Ncube G; Mugurungi O; Cowan FM
PLoS One; 2019; 14(3):e0213399. PubMed ID: 30856228
[TBL] [Abstract][Full Text] [Related]
6. Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe.
Bochner AF; Feldacker C; Makunike B; Holec M; Murenje V; Stepaniak A; Xaba S; Balachandra S; Tshimanga M; Chitimbire V; Barnhart S
J Int AIDS Soc; 2017 Feb; 19(1):21394. PubMed ID: 28362066
[TBL] [Abstract][Full Text] [Related]
7. Attitudes and decision-making about early-infant versus early-adolescent male circumcision: Demand-side insights for sustainable HIV prevention strategies in Zambia and Zimbabwe.
Sgaier SK; Sharma S; Eletskaya M; Prasad R; Mugurungi O; Tambatamba B; Ncube G; Xaba S; Nanga A; Gumede-Moyo S; Kretschmer S
PLoS One; 2017; 12(7):e0181411. PubMed ID: 28749979
[TBL] [Abstract][Full Text] [Related]
8. Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe.
Feldacker C; Bochner AF; Murenje V; Makunike-Chikwinya B; Holec M; Xaba S; Balachandra S; Mandisarisa J; Sidile-Chitimbire V; Barnhart S; Tshimanga M
PLoS One; 2018; 13(9):e0203292. PubMed ID: 30192816
[TBL] [Abstract][Full Text] [Related]
9. Novel Devices for Adolescent and Adult Male Circumcision.
Al Hussein Alawamlh O; Kim SJ; Li PS; Lee RK
Eur Urol Focus; 2018 Apr; 4(3):329-332. PubMed ID: 30007543
[TBL] [Abstract][Full Text] [Related]
10. Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe.
Njeuhmeli E; Kripke K; Hatzold K; Reed J; Edgil D; Jaramillo J; Castor D; Forsythe S; Xaba S; Mugurungi O
PLoS One; 2014; 9(5):e82533. PubMed ID: 24801515
[TBL] [Abstract][Full Text] [Related]
11. Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique.
Schutte C; Tshimanga M; Mugurungi O; Come I; Necochea E; Mahomed M; Xaba S; Bossemeyer D; Ferreira T; Macaringue L; Chatikobo P; Gundididza P; Hatzold K
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S96-S100. PubMed ID: 27331599
[TBL] [Abstract][Full Text] [Related]
12. Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe.
Mavhu W; Hatzold K; Ncube G; Xaba S; Madidi N; Keatinge J; Dhodho E; Samkange CA; Tshimanga M; Mangwiro T; Mugurungi O; Njeuhmeli E; Cowan FM
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S63-8. PubMed ID: 27331593
[TBL] [Abstract][Full Text] [Related]
13. Safety Profile of PrePex Male Circumcision Device and Client Satisfaction With Adolescent Males Aged 13-17 Years in Zimbabwe.
Tshimanga M; Hatzold K; Mugurungi O; Mangwiro T; Ncube G; Xaba S; Chatikobo P; Gundidza P; Samkange C; Dhlamini R; Murwira M; Gwinji G
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S36-42. PubMed ID: 27331588
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
Feldblum P; Martinson N; Bvulani B; Taruberekera N; Mahomed M; Chintu N; Milovanovic M; Hart C; Billy S; Necochea E; Samona A; Mhazo M; Bossemeyer D; Lai JJ; Lebinai L; Ashengo TA; Macaringue L; Veena V; Hatzold K
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S43-8. PubMed ID: 27331589
[TBL] [Abstract][Full Text] [Related]
15. HIV Incidence by Male Circumcision Status From the Population-Based HIV Impact Assessment Surveys-Eight Sub-Saharan African Countries, 2015-2017.
Hines JZ; Sachathep K; Pals S; Davis SM; Toledo C; Bronson M; Parekh B; Carrasco M; Xaba S; Mandisarisa J; Kamobyi R; Chituwo O; Kirungi WL; Alamo S; Kabuye G; Awor AC; Mmbando S; Simbeye D; Aupokolo MA; Zemburuka B; Nyirenda R; Msungama W; Tarumbiswa T; Manda R; Nuwagaba-Biribonwoha H; Kiggundu V; Thomas AG; Watts H; Voetsch AC; Williams DB
J Acquir Immune Defic Syndr; 2021 Aug; 87(Suppl 1):S89-S96. PubMed ID: 33765683
[TBL] [Abstract][Full Text] [Related]
16. A systems-based assessment of the PrePex device adverse events active surveillance system in Zimbabwe.
Adamson PC; Tafuma TA; Davis SM; Xaba S; Herman-Roloff A
PLoS One; 2017; 12(12):e0190055. PubMed ID: 29272320
[TBL] [Abstract][Full Text] [Related]
17. The PrePex device is unlikely to achieve cost-savings compared to the forceps-guided method in male circumcision programs in sub-Saharan Africa.
Obiero W; Young MR; Bailey RC
PLoS One; 2013; 8(1):e53380. PubMed ID: 23349708
[TBL] [Abstract][Full Text] [Related]
18. Rollout of ShangRing circumcision with active surveillance for adverse events and monitoring for uptake in Kenya.
Odoyo-June E; Owuor N; Kassim S; Davis S; Agot K; Serrem K; Otieno G; Awori Q; Hines J; Toledo C; Laube C; Kisia C; Aoko A; Ojiambo V; Mwandi Z; Juma A; Kigen B
PLoS One; 2019; 14(9):e0222942. PubMed ID: 31557208
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based identification of key beliefs explaining adult male circumcision motivation in Zimbabwe: targets for behavior change messaging.
Montaño DE; Kasprzyk D; Hamilton DT; Tshimanga M; Gorn G
AIDS Behav; 2014 May; 18(5):885-904. PubMed ID: 24443147
[TBL] [Abstract][Full Text] [Related]
20. PREDICTORS OF MALE CIRCUMCISION AMONG MEN AGED 15-35 YEARS IN HARARE, ZIMBABWE.
Mangombe K; Kalule-Sabiti I
J Biosoc Sci; 2018 Mar; 50(2):193-211. PubMed ID: 28482949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
